Table 2.
Study period | P* | Estimated means* (3weeks) | Pariwise significant results (LSD) | ||
---|---|---|---|---|---|
Baseline | 3weeks | ||||
Hb(mg/dl) | |||||
1.control | 11.01±2.58 | 10.92±1.68 | 0.002 | 11.05 | 2,3,4 vs.1 |
2.silymarin | 10.93±1.53 | 12.55±1.79 | 12.72 | ||
3.vit E | 11.29±2.46 | 12.61±2.18 | 12.60 | ||
4.combined | 11.88±1.63 | 12.68±1.90 | 12.36 | ||
GPX(Iu/gr-Hb) | |||||
1.control | 5.62±2.85 | 3.16±1.89 | 0.001 | 2.70 | 2,3,4 vs.1 & 4 vs.3 |
2.silymarin | 3.52±1.54 | 4.28±1.94 | 4.51 | ||
3.vit E | 3.93±2.18 | 4.22±1.63 | 4.43 | ||
4.combined | 3.98±2.03 | 5.78±3.51 | 5.89 | ||
MDA(nmol/ml) | |||||
1.control | 7.82±1.56 | 9.20±2.74 | 0.049 | 9.64 | 4 vs.1 |
2.silymarin | 9.67±3.08 | 9.40±2.54 | 9.12 | ||
3.vit E | 9.08±2.83 | 8.42±2.63 | 8.38 | ||
4.combined | 9.27±2.62 | 7.84±1.84 | 7.71 |
Based on ANCOVA: 3 week measurement of each variable as “dependent” and “baseline” as “covariate” (significance level= 0.05)
GPX=Glutathione peroxidase, MDA=Malondialdehyde, Hb=Hemoglobin